e-therapeutics plc has appointed Dr Paul Burke, Principal of Burke Bioventures LLC, as Chair of the Scientific Advisory Board (SAB). Dr Burke will work with the Company to appoint additional international advisors of the highest calibre to its newly formed SAB. Experience of SAB members will include genetics, computational approaches to drug discovery and deep drug development expertise, across small molecules and RNAi. Dr Burke brings over two decades of biopharmaceutical industry experience across a broad range of therapeutic modalities.